. Author manuscript; available in PMC: 2014 Sep 16.

Published in final edited form as: Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006627. doi: 10.1002/14651858.CD006627.pub2

Analysis 1.3. Comparison 1 ZIPRASIDONE versus AMISULPRIDE, Outcome 3 Global State: No clinically important change (as defined by the original studies).

Review: Ziprasidone versus other atypical antipsychotics for schizophrenia

Comparison: 1 ZIPRASIDONE versus AMISULPRIDE

Outcome: 3 Global State: No clinically important change (as defined by the original studies)